Clinical Trials are the only way to find a cure.
What are Clinical Trials?
Clinical trials are research studies conducted on people to determine if treatments are safe and effective.
Clinical trials are the only way to find a cure or new treatments for Alzheimer’s disease.
There are many types of clinical trials: treatment, diagnostic, prevention, screening and quality of life.
Why Should You Get Involved?
To gain access to potential treatments before they are widely available.
To contribute to the effort of finding more effective treatments for neurological disease.
To help myself and benefit others.
Today at least 70,000 volunteer participants are needed for more than 150 Alzheimer’s Disease and dementia clinical trials. More than 500,000 people must be screened to meet this number. There are trials recruiting people with Alzheimer’s disease, as well as healthy volunteers.
How do trials work? Why participate?
What are the risks? What progress has been made?
Find the answers to these and other questions.
How can I get involved?
- You can volunteer to participate in clinical trials and studies, even if you have no signs of the disease. The success of each trial depends on having enough participating patients.
- If you live in the Las Vegas area, contact the Lou Ruvo Center for Brain Health email@example.com or call 1.855.LOU.RUVO (1.855.568.7886).
- If you live in the Cleveland, OH area, call 1.216.445.9009 or 1.844.767.8629
Dr Marwan Sabbagh on placebos and consequences of opting out of clinical trials
Dr Marwan Sabbagh says exercise and cognitive stimulation can reduce risk for Alzheimer’s
Dr Marwan Sabbagh explains Alzheimer’s trials and disease modifying therapies
Dr Marwan Sabbagh remains an optimist despite 8 billion invested and 36 failed Alzheimer’s drugs
Featured Clinical Trials
Can exercise help older adults with memory loss? A message from Maria Shriver.
MILD COGNITIVE IMPAIRMENT
Can an anti-cancer drug be used to treat people with early symptoms of Alzheimer's disease? Help us find out. Consider joining our MCLENA-1 Study.
EXERT is a national, 18-month long, clinical trial to test whether physical exercise can slow the progression of early Alzheimer's disease related memory problems or mild cognitive impairment in older adults.